TP53 and thyroiditis: Thus, we performed the p53-MCL test on fresh PBMCs from 403 patients with sporadic cancers, including ovarian (n = 49), lung (n = 150), colon (n = 80), post-menopausal breast (n = 58), and both breast/thyroid (n = 69) cancer.